» Articles » PMID: 38422415

Cancer Conspicuity on Low-energy Images of Contrast-enhanced Mammography Compared With 2D Mammography

Overview
Specialties Oncology
Radiology
Date 2024 Feb 29
PMID 38422415
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Low-energy (LE) images of contrast-enhanced mammography (CEM) have been shown to be noninferior to digital mammography. However, our experience is that LE images are superior to 2D mammography. Our purpose was to compare cancer appearance on LE to 2D images.

Methods: In this IRB-approved retrospective study, seven breast radiologists evaluated 40 biopsy-proven cancer cases on craniocaudal (CC) and mediolateral oblique (MLO) LE images and recent 2D images for cancer visibility, confidence in margins, and conspicuity of findings using a Likert scale. Objective measurements were performed using contrast-to-noise ratio (CNR) estimated from regions of interest placed on tumor and background parenchyma. Reader agreement was evaluated using Fleiss kappa. Per-reader comparisons were performed using Wilcoxon test and overall comparisons used three-way analysis of variance.

Results: Low-energy images showed improved performance for visibility (CC LE 4.0 vs 2D 3.5, P < 0.001 and MLO LE 3.7 vs 2D 3.5, P = 0.01), confidence in margins (CC LE 3.2 vs 2D 2.8, P < 0.001 and MLO LE 3.1 vs 2D 2.9, P < 0.008), and conspicuity compared to tissue density compared to 2D mammography (CC LE 3.6 vs 2D 3.2, P < 0.001 and MLO LE 3.5 vs 2D 3.2, P < 0.001). The average CNR was significantly higher for LE than for digital mammography (CC 2.1 vs 3.2, P < 0.001 and MLO 2.1 vs 3.4, P < 0.001).

Conclusion: Our results suggest that cancers may be better visualized on the LE CEM images compared with the 2D digital mammogram.

Citing Articles

Contrast-Enhanced Mammography: A Literature Review of Clinical Uses for Cancer Diagnosis and Surgical Oncology.

Chung W, Tang Y, Cheung Y Cancers (Basel). 2025; 16(24.

PMID: 39766044 PMC: 11674923. DOI: 10.3390/cancers16244143.


Contrast-enhanced mammography improves patient access to functional breast imaging.

Taylor D, Kessell M, Parizel P J Med Imaging Radiat Oncol. 2024; 69(1):46-61.

PMID: 39482841 PMC: 11834761. DOI: 10.1111/1754-9485.13789.


State-of-the-art for contrast-enhanced mammography.

Covington M, Salmon S, Weaver B, Fajardo L Br J Radiol. 2024; 97(1156):695-704.

PMID: 38374651 PMC: 11027262. DOI: 10.1093/bjr/tqae017.


Diagnostic Contrast-Enhanced Mammography Performed Immediately Prior to Same-Day Biopsy: An Analysis of Index Lesion Enhancement Compared to Histopathology and Follow-up in Patients With Suspicious Ultrasound Findings.

Emory T, Hoven N, Nelson M, Church A, Rubin N, Kuehn-Hajder J J Breast Imaging. 2023; 5(1):40-47.

PMID: 36778652 PMC: 9901423. DOI: 10.1093/jbi/wbac081.


The Impact of Dense Breasts on the Stage of Breast Cancer at Diagnosis: A Review and Options for Supplemental Screening.

Gordon P Curr Oncol. 2022; 29(5):3595-3636.

PMID: 35621681 PMC: 9140155. DOI: 10.3390/curroncol29050291.